Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Exclusive licensing deals a tool for collaboration

15.04.2010
Exclusive licensing deals are a two-way safety net that fosters cooperation as new product ideas weave their way toward the marketplace, according to new research led by a University of Illinois business strategy expert.

Deepak Somaya says the findings reveal that granting rights to a sole partner is a tool to curb risk and leverage cooperation, not to corner the market when breakthrough innovations are ultimately launched.

“We found that exclusive licensing is very significantly about the collaboration needed to reach the marketplace and succeed, not about dominating the marketplace,” he said. “Past research theorized that exclusivity was largely about creating downstream monopolies to drive sales and profits.”

In short, the deals link innovators with partners who are skilled in taking new products to the marketplace, according to findings that will appear in the Strategic Management Journal. Those partners, in turn, develop a vested interest in success because exclusivity means no new licenses will water down earnings potential once the partner has helped the product succeed.

“Partners will be less willing to give 100 percent if they can’t reap the benefits in the end, so exclusivity provides an incentive for cooperation,” said Somaya, a professor of business administration in the nationally ranked U. of I. College of Business.

But exclusive deals also can be risky, according to the study, co-written by business professor Young Jun Kim, of Texas A&M International University, and Nicholas S. Vonortas, an economist at George Washington University.

Partners can turn out to be less effective than hoped or fledgling product innovations can turn out to have broader, more-profitable applications, such as a potential drug for Alzheimer’s disease that later proves useful to treat Parkinson’s disease, Somaya said.

Innovators can manage those risks by limiting the scope of exclusivity, according to the unique study, which analyzed more than 200 exclusive licensing deals involving publicly traded biotechnology, pharmaceutical and chemical firms.

A contract for an early-stage pharmaceutical breakthrough, for example, might grant exclusivity only for Alzheimer’s treatment while the inventor retains rights for all other potential applications.

“With early-stage technologies, the licensor doesn’t want to give away the store, but the licensee also wants protection because developing and commercializing the product will require a lot of investment,” Somaya said. “Scope restrictions address both of those concerns.”

Whether blanket or restricted, the study found that exclusive licensing is commonly used as a contractual “hostage” that innovators voluntarily give up as a sign of good faith that nurtures cooperation.

Somaya says hostages can provide incentives and safeguards for both creators of new product ideas and the sole partners signed on to commercialize them.

“There’s is simple analogy in car shopping. Dealers want you to test drive because it can close the sale. But how do they know you’ll come back? Well, it’s because they have your driver’s license or the keys to your car,” Somaya said.

“But there’s a danger in giving too much of a hostage away, which is where restricted exclusivity come in,” he said. “And in some cases, it may make sense to not give a hostage at all and license non-exclusively to multiple partners. If there isn’t a need for close cooperation, all it does is shackle your own feet.”

Somaya says giving away hostages can yield a level of cooperation that could never be spelled out in a contract, especially with early-stage product ideas that are still evolving.

“Incorporating hostages into licensing contracts is a valuable complement to detailed contractual clauses,” he said. “It creates incentives for partners to cooperate willingly and automatically, even when situations arise that they did not anticipate and even if the other party can’t observe the level of support being offered.”

Jan Dennis | EurekAlert!
Further information:
http://www.illinois.edu

Further reports about: Alzheimer Alzheimer’s Disease licensing deals

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

Im Focus: Bacteria harness the lotus effect to protect themselves

Biofilms: Researchers find the causes of water-repelling properties

Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...

Im Focus: Hydrogen Bonds Directly Detected for the First Time

For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel’s Swiss Nanoscience Institute network have reported the results in the journal Science Advances.

Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds. Molecules and sections of macromolecules are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

Media accreditation opens for historic year at European Health Forum Gastein

16.05.2017 | Event News

 
Latest News

New approach to revolutionize the production of molecular hydrogen

22.05.2017 | Materials Sciences

Scientists enlist engineered protein to battle the MERS virus

22.05.2017 | Life Sciences

Experts explain origins of topographic relief on Earth, Mars and Titan

22.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>